VTRS SEC filings (2026)

About this data#

Viatris Inc. (VTRS) has 541 filings on EDGAR going back to 2019: 12 annual reports, 20 quarterly reports and 72 current reports, plus proxy statements, insider forms and ownership schedules. Its latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. The most recent 8-K, on Oct 8, 2026, furnished a press release headed “Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies”. Over the last 13 months insiders sold $1.1M in 2 sales and bought $5,202 in 2 purchases; 129 other transactions (awards, exercises, tax withholding, gifts and plan purchases). Not investment advice.

Every row is a filing EDGAR lists for the registrants that have been Viatris Inc., read from the SEC’s submissions index each morning; a filing accepted after that read appears the next day. Where a company changed its filing entity (a holding-company reorganisation, Google into Alphabet) the predecessor’s filings are shown for the years it filed as the company, derived from the filings themselves. Dates are the filing date; the period is the report’s own. The latest 3 years of reports are listed in full, the next years to 10 without their 8-Ks, and older years are counted; the other forms are counted too, with the newest 25 of each of the latest 3 years shown. Insider transactions are the Form 4 and Form 5 documents themselves, filed since January 2026, every number as the insider filed it: a day’s lots are summed, a blank price adds its shares and no dollars, and a purchase through an employee stock plan is a plan purchase, not insider buying. An 8-K’s headline is the first line of the press release it furnishes (Exhibit 99), read from the filing and shown word for word; where two independent readings of the exhibit do not agree, the 8-K is described by its items instead. The documents stay on sec.gov, public domain, and every link opens the SEC’s copy. ChartRow does not summarise or interpret filings.

FAQ#

Where can I read VTRS's latest 10-K?

VTRS's latest annual report, a 10-K, was filed on Feb 26, 2026 for the fiscal year ended Dec 31, 2025. It is linked above and opens on EDGAR, the SEC's own site, where every exhibit is also listed.

When did VTRS last file an 8-K?

On Oct 8, 2026 it furnished a press release headed “Viatris Agrees to Acquire Pacira BioSciences, Advancing Its Innovative Medicines Strategy and Becoming a Leader in Non-Opioid Pain Therapies”. An 8-K reports a material event between quarterly reports; the one that furnishes the quarter's results is filed under Item 2.02, last on Aug 6, 2026.

Are VTRS insiders buying or selling?

Over the last 13 months insiders sold $1.1M in 2 sales and bought $5,202 in 2 purchases; 129 other transactions (awards, exercises, tax withholding, gifts and plan purchases). The most recent sale: Campbell Paul (See Remarks) sold 50,076 shares on Jun 25, 2026 for $810K, under a 10b5-1 plan. Every figure is as the insider filed it on Form 4; a sale under a 10b5-1 plan was scheduled in advance.

How many SEC filings has VTRS made?

541 filings are on EDGAR under the registrant records that have been Viatris Inc., going back to 2019; 335 of them are insider ownership forms (Forms 3, 4, 5 and 144).